Advertisement
Canada markets open in 34 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7293
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     
  • Bitcoin CAD

    86,883.12
    -4,217.04 (-4.63%)
     
  • CMC Crypto 200

    1,359.87
    -22.70 (-1.64%)
     
  • GOLD FUTURES

    2,340.10
    +1.70 (+0.07%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6960
    +0.0440 (+0.95%)
     
  • NASDAQ futures

    17,394.00
    -270.50 (-1.53%)
     
  • VOLATILITY

    16.70
    +0.73 (+4.57%)
     
  • FTSE

    8,078.29
    +37.91 (+0.47%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6821
    +0.0002 (+0.03%)
     

Stocks in play: Abattis Bioceuticals Corp.

Announced the pending release of “Comfort”, a nutraceutical designed to target chronic pain and inflammation. As previously announced, the Company hopes to launch Comfort on Cyber Monday through the Company’s wholly-owned subsidiary, Vergence Naturals Ltd. Abattis and Vergence unveil “Comfort” a new product line targeting Chronic Pain & Inflammation. Abattis Bioceuticals Corp. shares ATT:CNX are trading up 2.86 percent at $0.18.